IAVI reports its single-dose Lassa fever vaccine is safe and effective, paving way for advanced trials across West Africa.

Volunteers were monitored for 12 months post-vaccination, with immune responses activating both humoral and cellular immunity ...

Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

The cold months push our bodies toward comfort: slow mornings, thick sweaters, generous stews, and the spices we reach for do ...

In preclinical experiments, the combination of Trastuzumab PH1 + anti-PD1 outperforms the combination of Kadcyla® + anti-PD1 with a statistically significantly greater rate of Complete Responses (74% ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...

Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners' clinical development, recently presented its Next-Generation LNP advancements, a ...

Kidney transplantation is the treatment of choice for end-stage kidney disease, yet alloimmune responses remain the leading cause of graft dysfunction and ...

This review in Food Science & Nutrition synthesizes evidence showing that walnuts (Juglans regia L.) exert potent antioxidant ...